TERTpromoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas

TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma

(2015) G. Gandolfi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC

(2015) Jonathan R. George et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid

(2015) Ana-Maria Chindris et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis

(2015) Jen-Der Lin et al.   MEDICINE

Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization

(2015) Marina Muzza et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

TERTPromoter Mutations in Papillary Thyroid Microcarcinomas

(2015) Dario de Biase et al.   THYROID

TERTpromoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA

(2014) Na Wang et al.   CANCER

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay

(2014) Yuri E. Nikiforov et al.   CANCER

Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy

(2014) R. Liu et al.   ENDOCRINE-RELATED CANCER

Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma

(2014) Na Wang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer

(2014) Xiaoli Liu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

(2014) Miguel Melo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

(2014) Mingzhao Xing et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome-wide analysis of noncoding regulatory mutations in cancer

(2014) Nils Weinhold et al.   NATURE GENETICS

Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types

(2014) Nils J Fredriksson et al.   NATURE GENETICS

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

(2013) Xiaoli Liu et al.   ENDOCRINE-RELATED CANCER

Frequent SomaticTERTPromoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

(2013) Iñigo Landa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

(2013) P. S. Rachakonda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

Frequency of TERT promoter mutations in human cancers

(2013) João Vinagre et al.   Nature Communications

Association ofFOXE1Polyalanine Repeat Region with Papillary Thyroid Cancer

(2012) Martyn Bullock et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAFV600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer

(2010) Christine J. O’Neill et al.   SURGERY